NCT03446001: A trial that was reported late by TauRx Therapeutics Ltd
This trial has reported, although it was 94 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03446001 |
|---|---|
| Title | Randomized, Double-Blind, Placebo-Controlled, Three-Arm, 12-Month, Safety and Efficacy Study of TRx0237 Monotherapy in Subjects With Alzheimer's Disease Followed by a 12-Month Open-Label Treatment |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 1, 2017 |
| Completion date | March 31, 2022 |
| Required reporting date | March 31, 2025, midnight |
| Actual reporting date | July 3, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 94 |